Merck: Game-Changing Oncology Drugs Power Stock Surge

Group 1 - Merck's stock price has increased by 5% over the past four months, indicating positive market performance [1] Group 2 - Allka Research has over two decades of experience in investment, focusing on uncovering undervalued assets in various sectors including ETFs, commodities, technology, and pharmaceuticals [2] - The firm emphasizes a conservative investment approach, aiming to deliver substantial returns and strategic insights to clients [2] - Allka Research seeks to simplify investment strategies for both seasoned and novice investors, fostering a community of informed investors [2]